Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer

(2015) Sanjeev Krishna et al.   EBioMedicine

Randomized, Prospective, Three-Arm Study to Confirm the Auditory Safety and Efficacy of Artemether-Lumefantrine in Colombian Patients with Uncomplicated Plasmodium falciparum Malaria

(2012) Gabriel Carrasquilla et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Factors determining sensitivity or resistance of tumor cell lines towards artesunate

(2010) Serkan Sertel et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Murine malaria is associated with significant hearing impairment

(2010) Joachim Schmutzhard et al.   MALARIA JOURNAL

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines

(2010) Serkan Sertel et al.   MOLECULES

Anticancer activities of artemisinin and its bioactive derivatives

(2009) Gary L. Firestone et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand

(2008) Verena I Carrara et al.   MALARIA JOURNAL

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

(2008) Robert Gurkov et al.   MALARIA JOURNAL

Artemisinins: their growing importance in medicine

(2008) Sanjeev Krishna et al.   TRENDS IN PHARMACOLOGICAL SCIENCES